MLYS Earnings

Quarterly EPS
$-1.13
Q3 2024
$-0.98
Q4 2024
$-0.79
Q1 2025
$-0.66
Q2 2025
$-0.52
Q3 2025
$-0.40
Q4 2025
$-0.47
Q1 2026
$-2.85
Q2 2026
Latest RevenueN/A
Latest Net Income-241071000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$2.850-241071000-331.8%
Q1 2026-$0.470-39339000+40.5%
Q4 2025-$0.400-32234000+59.2%
Q3 2025-$0.520-36932000+54.0%
Q2 2025-$0.660-43274000+20.5%
Q1 2025-$0.790-42211000-12.9%
Q4 2024-$0.980-48946000-60.7%
Q3 2024-$1.130-56342000-98.2%
Q2 2024-$0.830-41014000
Q1 2024-$0.700-31508000
Q4 2023-$0.610-24389000
Q3 2023-$0.570-22760000
Mineralys Therapeutics (MLYS) — Earnings